Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with multiple myeloma (a type of blood cancer) and need treatment, including at least 6 months of ongoing treatment with medications.
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard medical scoring system called the ECOG scale (confirm with trial site for exact score details).
- People who are 18 years of age or older.
- People who are willing and able to take part in a training or exercise program at least 3 times per week.
- People who are willing to attend all planned follow-up visits as part of the study.
- People who are able to understand the study and agree to take part in it.
- People who have given their agreement to participate in writing.
- People who have a sufficient level of written and spoken German to complete the study questionnaires.
Who may not be able to join:
- People who have physical or mental health conditions that would prevent them from safely taking part in the exercise or training program, or from attending the planned check-up visits.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dapunt, University Hospital Heidelberg
Phone: +49 622156 32765
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of at least 48 out of 72 training sessions with the focus on fall prevention within 24 weeks; Effectivity (fear of falling)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.